Prostate cancer: open trials in Peru

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 1258), Concepción · INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1256), Lima · Aliada-Oncologìa ( Site 1257), Lima · Oncosalud-Clinical Research ( Site 1260), Lima · IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1254), Lima · Clínica Sánchez Ferrer ( Site 1261), Trujillo

  Registry updated 2026-11-05

• NCT06925737

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Unidad de Investigacion Oncologia Clínica Piura ( Site 0669), Castilla · Hospital Cayetano Heredia ( Site 0667), Lima · Instituto Neuro Cardiovascular de las Americas ( Site 0668), Lima · Instituto Nacional de Enfermedades Neoplásicas ( Site 0665), Lima · IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0666), Lima

  Registry updated 2026-10-30

• NCT06136650

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1052), Lima · INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1054), Lima · Oncosalud-Clinical Research ( Site 1057), Lima · Aliada-Oncologìa ( Site 1055), Lima

  Registry updated 2026-10-20

• NCT06952803

  A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  Trial Treatment · Phase 3 · AstraZeneca

  Lima · Trujillo

  Registry updated 2026-10-14

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error